Results 101 to 110 of about 511,435 (213)

Predictive Value of Composite Inflammatory Markers for Stroke Prognosis: A Prospective Cohort Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Novel composite inflammatory markers' role in stroke prognosis is understudied, and the best predictor is unclear, requiring further exploration. Objectives This study aimed to systematically evaluate the associations of 6 novel composite inflammatory markers on stroke prognosis.
Bing Wu   +7 more
wiley   +1 more source

Asymptotic Properties of Kaplan-Meier Estimator for Censored Dependent Data

open access: yes, 1997
In some long term studies, a series of dependent and possibly censored failure times may be observed. Suppose that the failure times have a common marginal distribution function, and inferences about it are of our interest.
Zongwu Cai
core  

Integrated PANoptosis Profiling Identifies Immunosuppressive Subtypes and a Prognostic Signature With Functional Validation of MLKL in Glioblastoma

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective The prognosis of glioblastoma (GBM) remains highly unfavorable, largely due to high tumor heterogeneity and an immunosuppressive microenvironment. However, the functional role of PANoptosis in this context is poorly understood. Methods Patients were stratified via K‐means clustering. A risk score model was constructed using prognosis‐
Langfei Tian   +6 more
wiley   +1 more source

COMPARISON OF CONFIDENCE INTERVALS FOR THE SURVIVAL FUNCTION IN THE PRESENCE OF RIGHT CENSORING COMPARACIÓN DE INTERVALOS DE CONFIANZA PARA LA FUNCIÓN DE SUPERVIVENCIA CON CENSURA A DERECHA

open access: yesRevista Colombiana de Estadística, 2011
This work compares methods to find confidence interval for the survival function such as the resampling methods Bootstrap, applied to the Kaplan-Meier and Nelson-Aalen estimators.
Ramírez Javier
doaj  

Disease Course After Anti‐CD20 Discontinuation in Secondary Progressive Multiple Sclerosis—A Multicenter Long‐Term Longitudinal Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To describe long‐term outcomes after anti‐CD20 discontinuation in selected patients with secondary progressive multiple sclerosis (SPMS) who remained without subsequent disease‐modifying therapy (DMT). Methods We retrospectively analyzed data from four centers in Austria and Switzerland.
Ferdinand Otto   +12 more
wiley   +1 more source

Survival Analysis of Patients with Lung Cancer Using Cox Regression Model

open access: yesJournal of Mazandaran University of Medical Sciences, 2018
Background and purpose: Lung cancer is the third cause of death and amongst the five common cancers in Iran. The aim of this study was to analyze the survival rate of patients with lung cancer and identifying the variables influencing their survival ...
Fatemeh Babanejhad   +5 more
doaj  

“Low‐Positive” MOG‐IgG Cases Among Adults With a First Event Suggestive of Multiple Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To determine the prevalence and clinical characteristics of patients with “low‐positive” (LP) MOG‐IgG (titres 1:160–1:320) among adults with a first demyelinating event (FDE) suggestive of multiple sclerosis (MS). Methods From the Barcelona CIS inception cohort, we included adult patients with serum collected ≤ 6 months from the FDE.
Javier Villacieros‐Álvarez   +29 more
wiley   +1 more source

The multiple imputations based Kaplan-Meier estimator

open access: yes
We derive the asymptotic distribution of the multiple imputations-based Kaplan-Meier estimator from right censored data with missing censoring indicators.
Subramanian, Sundarraman
core  

Almost sure asymptotic representation for a class of functionals of the Kaplan-Meier estimator

open access: yes, 1991
This paper deals with censored data estimation of a general class of von Mises-type functionals of the survival time distribution $F$. Conditions are given under which an almost sure asymptotic representation holds for the estimator, obtained by applying
VERAVERBEKE, Noel, Gijbels, Irene
core   +1 more source

Anti‐CD20 Discontinuation Versus Continuation in People Aged Over 50 With Non‐Active Multiple Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To determine whether discontinuing anti‐CD20 therapy in people with relapsing‐onset MS aged over 50 is associated with an increased risk of relapse, inflammatory activity, confirmed disability accrual, and serious infection compared with continuing therapy.
Alexia Moukhine   +40 more
wiley   +1 more source

Home - About - Disclaimer - Privacy